Wearable MRI scanner can diagnose cancer—and may eventually read minds

A new device that functions the same way as an MRI machine could change the way clinicians diagnose cancer and heart disease. Its developers also say it could eventually read people's minds. 

Openwater, a San Francisco-based start-up, has developed the new wearable scanning device that uses infrared light to scan five to six inches into the body, according to a recent article by the Financial Times.  

"The tool can be used to spot a tumor by detecting the surrounding blood vessels and to see where arteries are clogged," according to story. "One day, it could follow the flow of oxygenated blood to different areas of the brain, tracking our thoughts and desires."   

Openwater founder and CEO Mary Lou Jepsen told the Financial Times that the new device is cheaper than a standard MRI machine with higher resolution. The device's operation benefits from tiny pixel size on display screens, physics focusing on the ability to assess the scattering of light and analyzing oxygenated blood flow to determine brain activity.

Jepsen, a former holograms and virtual reality expert for Google and Facebook, expects the device will have little trouble being approved by the U.S. Food and Drug Administration because it uses infrared light technology, which has already been used in numerous clinical settings.

Read more at the link below:

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.